In HGC-27 cells, the increase in NOX1 protein following cisplatin treatment did not reach statistical significance, highlighting a cell-type-dependent difference in response.
← all excerpts
Hesperadin sensitizes gastric cancer cells to cisplatin via NOX1-dependent oxidative stress.
1
—
—